GIA
EW icon

Gateway Investment Advisers’s Edwards Lifesciences EW Stock Holding History

Gateway Investment Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
14,402
+1,101
+8% +$92.2K 0.01% 377
2026
Q1 		$1.07M Buy
13,301
+1,067
+9% +$88K 0.01% 332
2025
Q4 		$1.04M Buy
12,234
+602
+5% +$49.4K 0.01% 366
2025
Q3 		$905K Buy
11,632
+123
+1% +$9.61K 0.01% 342
2025
Q2 		$900K Sell
11,509
-408
-3% -$30.4K 0.01% 324
2025
Q1 		$864K Buy
11,917
+336
+3% +$24K 0.01% 344
2024
Q4 		$857K Buy
11,581
+5,726
+98% +$401K 0.01% 337
2024
Q3 		$386K Sell
5,855
-177,055
-97% -$12.9M ﹤0.01% 418
2024
Q2 		$16.9M Sell
182,910
-20,614
-10% -$1.83M 0.19% 102
2024
Q1 		$19.4M Sell
203,524
-49,813
-20% -$4.18M 0.22% 98
2023
Q4 		$19.3M Buy
253,337
+27,519
+12% +$1.91M 0.23% 105
2023
Q3 		$15.6M Sell
225,818
-599
-0.3% -$48.1K 0.2% 112
2023
Q2 		$21.4M Buy
226,417
+11
+0% +$956 0.25% 100
2023
Q1 		$18.7M Sell
226,406
-3,797
-2% -$298K 0.23% 112
2022
Q4 		$17.2M Buy
230,203
+4,629
+2% +$357K 0.21% 118
2022
Q3 		$18.6M Sell
225,574
-44,663
-17% -$4.3M 0.23% 110
2022
Q2 		$25.7M Buy
270,237
+33,877
+14% +$3.51M 0.29% 91
2022
Q1 		$27.8M Sell
236,360
-32,458
-12% -$3.64M 0.27% 92
2021
Q4 		$34.8M Sell
268,818
-729
-0.3% -$85K 0.33% 81
2021
Q3 		$30.5M Sell
269,547
-327
-0.1% -$37.3K 0.32% 88
2021
Q2 		$28M Sell
269,874
-613
-0.2% -$57.8K 0.29% 91
2021
Q1 		$22.6M Sell
270,487
-6,468
-2% -$547K 0.25% 103
2020
Q4 		$25.3M Buy
276,955
+2,185
+0.8% +$181K 0.28% 91
2020
Q3 		$21.9M Sell
274,770
-101
-0% -$7.88K 0.25% 96
2020
Q2 		$19M Sell
274,871
-26,476
-9% -$1.88M 0.22% 101
2020
Q1 		$18.9M Buy
301,347
+32,226
+12% +$2.32M 0.23% 102
2019
Q4 		$20.9M Sell
269,121
-28,611
-10% -$2.23M 0.21% 120
2019
Q3 		$21.8M Sell
297,732
-48,474
-14% -$3.41M 0.22% 118
2019
Q2 		$21.3M Sell
346,206
-1,242
-0.4% -$75.1K 0.19% 126
2019
Q1 		$22.2M Sell
347,448
-17,472
-5% -$997K 0.2% 125
2018
Q4 		$18.6M Buy
364,920
+336,000
+1,162% +$17M 0.18% 126
2018
Q3 		$1.68M Sell
28,920
-477
-2% -$23.3K 0.01% 390
2018
Q2 		$1.43M Sell
29,397
-3,804
-11% -$178K 0.01% 411
2018
Q1 		$1.54M Sell
33,201
-3,897
-11% -$169K 0.01% 414
2017
Q4 		$1.39M Sell
37,098
-2,895
-7% -$106K 0.01% 437
2017
Q3 		$1.46M Sell
39,993
-1,266
-3% -$48.3K 0.01% 442
2017
Q2 		$1.63M Sell
41,259
-879
-2% -$32.1K 0.01% 410
2017
Q1 		$1.32M Sell
42,138
-4,596
-10% -$144K 0.01% 423
2016
Q4 		$1.46M Sell
46,734
-177
-0.4% -$5.74K 0.01% 418
2016
Q3 		$1.89M Sell
46,911
-501
-1% -$18.9K 0.02% 379
2016
Q2 		$1.58M Sell
47,412
-972
-2% -$33.3K 0.01% 407
2016
Q1 		$1.42M Sell
48,384
-22,419
-32% -$619K 0.01% 411
2015
Q4 		$1.86M Buy
70,803
+879
+1% +$22.8K 0.02% 409
2015
Q3 		$1.66M Sell
69,924
-5,010
-7% -$121K 0.01% 423
2015
Q2 		$1.78M Sell
74,934
-972
-1% -$21.9K 0.01% 429
2015
Q1 		$1.8M Sell
75,906
-252
-0.3% -$5.65K 0.02% 426
2014
Q4 		$1.62M Sell
76,158
-1,248
-2% -$25.1K 0.01% 457
2014
Q3 		$1.32M Sell
77,406
-600
-0.8% -$9.47K 0.01% 512
2014
Q2 		$1.12M Buy
78,006
+8,874
+13% +$120K 0.01% 540
2014
Q1 		$855K Sell
69,132
-2,748
-4% -$31.7K 0.01% 556
2013
Q4 		$788K Sell
71,880
-2,700
-4% -$30.4K 0.01% 562
2013
Q3 		$866K Buy
74,580
+5,082
+7% +$59.5K 0.01% 533
2013
Q2 		$778K Buy
+69,498
New +$823K 0.01% 522

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Gateway Investment Advisers's EW Position: Q2 2026 in Review

Gateway Investment Advisers increased its Edwards Lifesciences (EW) stake by 8.3% in Q2 2026, buying an estimated $92.2K and bringing the position to 14,402 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #377.

Gateway Investment Advisers first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.8M in Q4 2021. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Gateway Investment Advisers held 14,402 shares of Edwards Lifesciences worth $1.3M as of Q2 2026.
  • Gateway Investment Advisers bought 1,101 Edwards Lifesciences shares in Q2 2026, an estimated $92.2K.
  • Edwards Lifesciences made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #377 holding.
  • Gateway Investment Advisers first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Edwards Lifesciences position peaked at $34.8M in Q4 2021.
  • 327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.